Gilead Sciences (GILD) Acquisitions (2011 - 2026)

Gilead Sciences (GILD) has reported Acquisitions for 10 consecutive years, with $11.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Acquisitions rose 53276.19% year-over-year to $11.2 billion; the trailing twelve-month figure through Jun 2026 stood at $12.1 billion (up 1187.97% YoY), and the FY2025 full-year result was $1.1 billion, down 77.89% from the prior year.
• Acquisitions improved to $11.2 billion in Q2 2026 per GILD's latest filing, from $109.0 million in the prior quarter.
• Across five years, Acquisitions topped out at $11.2 billion in Q2 2026 and bottomed at $21.0 million in Q2 2025.
• Historically, Acquisitions has averaged $1.1 billion across 5 years, with a median of $276.0 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Acquisitions plunged 93.25% in 2025, then jumped 53276.19% in 2026.
• Over 5 years, Acquisitions stood at $218.0 million in 2022, then climbed by 27.98% to $279.0 million in 2023, then tumbled by 73.12% to $75.0 million in 2024, then jumped by 712.0% to $609.0 million in 2025, then soared by 1740.56% to $11.2 billion in 2026.
• According to Business Quant data, Acquisitions over the past three periods registered $11.2 billion, $109.0 million, and $609.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.